Login / Signup

Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.

Yanan SunLingyan YanJihua GuoJun ShaoRong Jia
Published in: Cancer chemotherapy and pharmacology (2019)
SRSF3 downregulation by ASO sensitizes cancer cells to PTX treatment.
Keyphrases
  • breast cancer cells
  • cell proliferation
  • signaling pathway
  • induced apoptosis
  • combination therapy
  • oxidative stress
  • replacement therapy